Cited by 248Mesenchymal stem cell researchHematopoietic Stem Cell TransplantationPluripotent Stem Cells Research

The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy

Hoogduijn, Martin J, Popp, Felix, Verbeek, Richard, Masoodi, Mojgan, Nicolaou, Anna, Baan, Carla, Dahlke, Marc-H·2010·International Immunopharmacology

Abstract

There is growing interest in the use of mesenchymal stem cells (MSC) for immune therapy. Clinical trials that use MSC for treatment of therapy resistant graft versus host disease, Crohn's disease and organ transplantation have initiated. Nevertheless, the immunomodulatory effects of MSC are only partly understood. Clinical trials that are supported by basic research will lead to better understanding of the potential of MSC for immunomodulatory applications and to optimization of such therapies. In this manuscript we review some recent literature on the mechanisms of immunomodulation by MSC in vitro and animal models, present new data on the secretion of pro-inflammatory and anti-inflammatory cytokines, chemokines and prostaglandins by MSC under resting and inflammatory conditions and discuss the hopes and expectations of MSC-based immune therapy.

Integrity signals

Registry

Crossref · 10.1016/j.intimp.2010.06.019

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mesenchymal stem cells secrete anti-inflammatory cytokines such as IL-10 and vascular endothelial growth factor (VEGF), and are being explored for their immunomodulatory capabilities.

    “Due to their ability to secrete anti-inflammatory cytokines such as IL-10 and vascular endothelial growth factor (VEGF), they are additionally being explored for their immunomodulatory capabilities [76,77].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hoogduijn, M. J., Popp, F., Verbeek, R., Masoodi, M., Nicolaou, A., Baan, C., & Dahlke, M.-H.
Affiliations
  • Erasmus MC (NL)
  • University of Regensburg (DE)
  • University of Bradford (GB)
Corresponding author
Hoogduijn, Martin J
Venue
International Immunopharmacology
Publisher
Elsevier BV
Published
2010-12
Volume
10
Issue
12
Pages
1496-1500
ISSN
1567-5769 (ISSN-L)
OpenAlex
W2166106062
Cited by
248
References
48
Citations by year
2026: 3 · 2025: 8 · 2024: 5 · 2023: 5 · 2022: 10 · 2021: 15 · 2020: 5 · 2019: 18 · 2018: 26 · 2017: 23 · 2016: 27 · 2015: 23 · 2014: 23 · 2013: 24 · 2012: 17
FWCI
8.08
Type
journal article
Language
en
Open access
closed
Locations
  • International Immunopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Bradford Scholars (University of Bradford) (submittedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Keywords
mesenchymal stem cells, immunomodulation, immunotherapy, graft-versus-host disease, Crohn's disease, organ transplantation, cytokine production, chemokines, prostaglandins, anti-inflammatory activity, pro-inflammatory effects
MeSH terms
Animals, Clinical Trials as Topic, Graft vs Host Disease, Humans, Immunotherapy, Prostaglandins, Cytokines, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review